Company News in the Life Science Industry

Reset 

BerGenBio ASA: Results for the Fourth Quarter and Full Year 2017

BERGEN, Norway, Feb. 13, 2018 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer indications, announces its results for the fourth quarter and full year 2017. A presentation of the results... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018
Related companies:  BerGenBio ASA

Ping An Technology Applies AI to Healthcare, Delivering Solutions that Benefit the General Public

SHANGHAI, Feb. 13, 2018 /PRNewswire/ -- The brand image of a company is not only reflected in its leading technologies and capital strength but also in its social responsibility and corporate value. Ping An Technology, the financial and health technology subsidiary of one of China's leading life... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018
Related companies:  Ping-Tung Agricultural Biotechnology Park (PABP)

Cedrus Investments' Chairman Mr. Rani Jarkas is Invited to Speak at the Hong Kong Biotech Invest and Partnering 2018

HONG KONG, Feb. 13, 2018 /PRNewswire/ -- The Chairman of Cedrus Investments ("Cedrus"), Mr. Rani Jarkas, is invited as the keynote speaker at the Asian Investment Series of the Hong... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018
Related companies:  Cedrus Investments HK Ltd

Golden Meditech Declares a Special Dividend to Shareholders

HONG KONG, Feb. 13, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) (the "Company"), a leading integrated healthcare enterprise in China, is pleased to announce that the board of directors of the Company (the "Board") declares a special cash dividend of... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018
Related companies:  Golden Meditech Holdings Limited

Nitin Gadkari Launches Madhavbaug's Gram Sanjivani Yojana to Boost Rural Healthcare

NAGPUR, India, February 13, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 13 Feb 2018

Sandoz announces US FDA approval and launch of Glatopa® 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis

HOLZKIRCHEN, Germany, Feb. 13, 2018 /PRNewswire/ -- Sandoz, a Novartis division, today announced the US FDA approval and launch of Glatopa(®) (glatiramer acetate injection) 40 mg/mL.

Read more ››
By: PR Newswire Association LLC. - 13 Feb 2018
Related companies:  Sandoz International GmbH

Rishikul Yogshala Launches Rishikul Ayurshala in Kerala, India

VARKALA, India, February 13, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 13 Feb 2018

Moberg Pharma AB Year-end Report 2017

STOCKHOLM, Feb. 13, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 13 Feb 2018
Related companies:  Moberg Pharma AB

InDex Pharmaceuticals Presents Mechanism of Action Data for Cobitolimod at the ECCO Congress

STOCKHOLM, February 13, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 13 Feb 2018
Related companies:  InDex Pharmaceuticals Holding AB

WntResearch Delays Start of Phase 2 Study With Foxy-5

STOCKHOLM, Feb. 13, 2018 /PRNewswire/ -- WntResearch AB announces today that, after reviewing available research results and further consultations with experts in oncology and surgery, the company has revised the design of the planned Phase 2 clinical study of its drug candidate Foxy-5. The... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018
Related companies:  WntResearch

BC Platforms to Provide Real World Evidence Solutions to Pfizer in Cardiovascular Diseases

BASEL, Switzerland and BOSTON, February 13, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 13 Feb 2018

Oracle Argus Supports E2B(R3) Exchange with the European Medicines Agency's Enhanced EudraVigilance System

REDWOOD SHORES, Calif., Feb. 13, 2018 /PRNewswire/ -- Oracle Health Sciences today announced that the latest release of Oracle Argus, the company's safety and pharmacovigilance software, fully supports E2B(R3) exchange with the European Medicines Agency's (EMA's) enhanced EudraVigilance (EV)... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018
Related companies:  Oracle Capital LLC | Oracle Investment Management, Inc | Gene Oracle Inc.

Delphi Behavioral Health Group Appoints New Chief Medical Officer

FORT LAUDERDALE, Fla., Feb. 13, 2018 /PRNewswire/ -- Delphi Behavioral Health Group, a leading nationwide provider of detox and addiction treatment programs, announced today the appointment of Dr. Neeraj Gandotra, MD as... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018

GNC and Harbin Pharmaceutical Announce $300 Million Strategic Investment and China Joint Venture

PITTSBURGH, Feb. 13, 2018 /PRNewswire/ -- GNC Holdings, Inc. (NYSE: GNC) (the "Company") today announced it has reached an agreement regarding a strategic partnership and China joint venture agreement with Harbin Pharmaceutical Group Holding Co., Ltd ("Hayao"), a leading pharmaceutical company... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018
Related companies:  GNC Corporation

ImmunoCellular Therapeutics Announces Update on Financial Condition

LOS ANGELES, Feb. 13, 2018 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE American: IMUC), a biotechnology company developing immunotherapies for the treatment of cancer based on its Stem-to-T-Cell research program, announced today that during the fourth quarter ended... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018
Related companies:  ImmunoCellular Therapeutics, Ltd.

Largest Shareholder of ZIVO Bioscience, Inc. to extend maturity date of its Convertible Debt

Read more ››
By: Nasdaq / GlobenewsWire - 13 Feb 2018

MediciNova Announces Closing of Underwritten Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 13 Feb 2018
Related companies:  MediciNova, Inc.

Daré Bioscience, Inc. Announces Proposed Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 13 Feb 2018
Related companies:  Daré Bioscience, Inc.

Gallup and Sharecare Release 2017 State Well-Being Rankings

Read more ››
By: Nasdaq / GlobenewsWire - 13 Feb 2018

Orkla Food Ingredients Expands its Acrylamide-Reducing Yeast Technology Licence Agreement with Renaissance BioScience Corp.

Read more ››
By: Nasdaq / GlobenewsWire - 13 Feb 2018
Related companies:  Renaissance Bioscience Co.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25

Explore our database of over 40,000 companies